(Q51632850)
Statements
Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. (English)
1 reference
S Korn
1 reference
A Thielen
1 reference
S Seyfried
1 reference
C Taube
1 reference
O Kornmann
1 reference
R Buhl
1 reference
9 June 2009
1 reference
103
1 reference
11
1 reference
1725-1731
1 reference